Insiders · Profile

Davis Jennifer L.

CEO - Health Care at Procter & Gamble. Filing since 17 Aug 2022. CIK 0001916665

Company
Date
Role
Action
Shares
Amount
Of holding
2 Oct 2025
CEO - Health Care
Sold at will
3,227
$491.25K
5.0%
19 Aug 2025
CEO - Health Care
Sold at will
8,596
$1.35M
11.7%
29 Apr 2025
CEO - Health Care
Sold at will
1,000
$161.38K
1.9%
2 Oct 2024
CEO - Health Care
Sold at will
4,447
$763.35K
7.8%
20 Aug 2024
CEO - Health Care
Sold at will
6,223
$1.05M
9.8%
17 Aug 2023
CEO - Health Care
Sold at will
5,761
$880.55K
10.9%
24 Apr 2023
CEO - Health Care
Sold at will
23,943
$3.72M
37.5%
23 Aug 2022
CEO - Health Care
Sold, plan not stated
27,809
$4.11M
45.8%
17 Aug 2022
CEO - Health Care
Sold, plan not stated
7,621
$1.14M
18.8%
9 decisions on file.